Search

Author/Creator Hou, Zhaohua

4. Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1. (2nd November 2022)

Authors:
Quach, Hue Tu; Hou, Zhaohua; Bellis, Rebecca Y.; Saini, Jasmeen K.; Amador-Molina, Alfredo; Adusumilli, Prasad S.; Xiong, Yuquan
Journal:
Expert opinion on investigational drugs
Issue:
Volume 31:Number 11(2022)
Page Start:
1187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis. Issue 1 (22nd January 2020)

Authors:
Yi, Shuhua; Zhang, Yu; Xiong, Wenjie; Chen, Weiwei; Hou, Zhaohua; Yang, Yang; Yan, Yuting; Wei, Yunbo; Cui, Rui; Wang, Huijun; Yu, Zhen; Li, Heng; Li, Zengjun; Liu, Wei; Lv, Rui; Wang, Tingyu; Ru, Kun; Zou, Dehui; Shu, Minglei; Qiu, Lugui
Journal:
Clinical & translational immunology
Issue:
Volume 9:Issue 1(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗